Eir Partners Capital has announced it has closed the second iteration of its private equity fund with $496 million in capital commitments.

The fund, Eir Partners Investment Program II, was oversubscribed.

Eir, based in Miami, is a middle market private equity firm focused on healthcare technology and tech-enabled services. Founded in 2015, Eir’s targeted

GTCR is expected to acquire Caravel Autism Health, according to industry reports.

Caravel Autism Health, founded in 2009 and based in Green Bay, Wisconsin, is a provider of in-home intensive, post-intensive, pre-intensive and diagnostic evaluation services to children with autism spectrum disorder. The company operates more than 60 locations in eight states.


On May 14, 2024, the Biden administration — following the conclusion of the U.S. trade representative’s statutory review of Section 301 tariffs imposed on Chinese-origin goods in 2018 — announced prospective increases to tariffs on a range of goods manufactured in China. The administration directed the USTR to increase tariffs on $18 billion of imports

This Week in Washington: House appropriators release FY2025 topline appropriations levels; Senate Finance Committee releases white paper on Medicare physician payment reforms; House Energy and Commerce Committee Subcommittee on Health marks up 21 bills.


House Appropriators Release FY2025 Topline Funding Amounts

On May 16, House appropriators released topline funding amounts for the fiscal year

Applicable Provider Types: All

Is Your Entity in Compliance?

The Health Insurance Portability and Accountability Act of 1996, as modified by the Health Information Technology for Economic and Clinical Health Act of 2009 (HIPAA) requires Covered Entities (CEs), Business Associates (BAs) and Business Associate subcontractors to enter into written agreements governing each party’s rights and

This Week in Washington: House Ways and Means Committee marks up telehealth legislation; CMS extends state Medicaid unwinding flexibilities; Senate HELP Committee ranking member releases white paper outlining possible NIH reforms.


House Ways and Means Committee Marks Up Telehealth Legislation

On May 8, the House Ways and Means Committee marked up and reported out

On April 19, 2024, the U.S. Environmental Protection Agency announced the designation of two per- and polyfluoroalkyl substances (PFAS)—perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) and their salts and structural isomers—as hazardous substances under the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA).[1]  In its designation, the EPA has identified over 85 industries it believes are most likely to be directly or indirectly affected by the designation.